CIK 0000882095
- Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943047598
- Phone
- +1 650-574-3000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $36,996,096
- in 12 filings, $37.0M under 10b5-1 plans
Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-03 | Kramer Kelly A. Director | Grant or award · Non-qualified Stock Option (Right to Buy) | +10,173 | $79.45 | $808K | 10,173 |
| 2023-05-03 | BARTON JACQUELINE K Director | Grant or award | +1,887 | 22,230 | ||
| 2023-05-03 | BARTON JACQUELINE K Director | Grant or award · Non-qualified Stock Option (Right to Buy) | +10,173 | $79.45 | $808K | 10,173 |
| 2023-05-03 | Bluestone Jeffrey Director | Grant or award · Restricted Stock Unit | +1,887 | 1,887 | ||
| 2023-05-03 | Bluestone Jeffrey Director | Grant or award · Non-qualified Stock Option (Right to Buy) | +10,173 | $79.45 | $808K | 10,173 |
| 2023-05-03 | Horning Sandra Director | Grant or award | +1,887 | 3,631 | ||
| 2023-05-03 | Horning Sandra Director | Grant or award · Non-qualified Stock Option (Right to Buy) | +10,173 | $79.45 | $808K | 10,173 |
| 2023-05-03 | Lofton Kevin E Director | Grant or award | +1,887 | 92,653 | ||
| 2023-05-03 | Lofton Kevin E Director | Grant or award · Non-qualified Stock Option (Right to Buy) | +10,173 | $79.45 | $808K | 10,173 |
| 2023-05-03 | Rodriguez Javier Director | Grant or award | +1,887 | 8,392 | ||
| 2023-05-03 | Rodriguez Javier Director | Grant or award · Non-qualified Stock Option (Right to Buy) | +10,173 | $79.45 | $808K | 10,173 |
| 2023-05-03 | MANWANI HARISH Director | Grant or award | +1,887 | 11,382 | ||
| 2023-05-03 | MANWANI HARISH Director | Shares withheld for taxes | −368 | $79.45 | $29K | 11,014 |
| 2023-05-03 | MANWANI HARISH Director | Grant or award · Non-qualified Stock Option (Right to Buy) | +10,173 | $79.45 | $808K | 10,173 |
| 2023-05-03 | WELTERS ANTHONY Director | Grant or award | +1,887 | 7,922 | ||
| 2023-05-03 | WELTERS ANTHONY Director | Grant or award · Non-qualified Stock Option (Right to Buy) | +10,173 | $79.45 | $808K | 10,173 |
| 2023-05-01 | Lofton Kevin E Director | Gift | −12,868 | 90,766 | ||
| 2023-03-30 | Lofton Kevin E Director | Grant or award · Phantom Stock | +28.58 | 3,132.35 | ||
| 2023-03-13 | Parsey Merdad Chief Medical Officer | Sale | −6,126 | $78.99 | $484K | 70,130 |
| 2023-03-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise | +19,488 | 378,983 |
Page 35 of 43 · 851 trades